Unidad de Microbiología, Hospital El Bierzo, Ponferrada, Spain; Departamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo, Oviedo, Spain; Grupo de Microbiología Traslacional, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Departamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo, Oviedo, Spain; Grupo de Microbiología Traslacional, Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
J Hosp Infect. 2020 Aug;105(4):659-662. doi: 10.1016/j.jhin.2020.04.044. Epub 2020 May 1.
Carbapenemase-producing Enterobacterales (CPE) represent a serious threat to public health. Clinical microbiology laboratories (CMLs) need effective protocols for screening and confirmation of CPE.
To prospectively evaluate an algorithm for the screening of carbapenemase-producing Klebsiella pneumoniae in an OXA-48 endemic hospital.
The algorithm was based on a disc diffusion assay using ertapenem and temocillin, which also served as a purity check for routine automated antimicrobial susceptibility testing. All isolates with minimal inhibitory concentrations >0.5 mg/L or zone inhibition diameters <25 mm for ertapenem (Criterion 1) and <12 mm for temocillin (Criterion 2) were tested sequentially by an OXA-48 lateral flow immunochromatographic assay and a multiplex polymerase chain reaction targeting VIM, KPC and OXA-48. If neither test was positive, the modified Hodge test or CARBA NP test was used.
Over 2 years, 2487 K. pneumoniae were assessed by the algorithm proposed, and 378 (15.20%) met both criteria. Of these, 98.68% (373/378) were either confirmed as OXA-48 producers or originated from patients with a previous CPE isolate that maintained the same resistance phenotype over time. The remaining three K. pneumoniae were VIM producers. Only two of the 378 isolates (0.53%) did not produce carbapenemase, despite meeting Criteria 1 and 2.
The algorithm described combined the most sensitive carbapenem for CPE detection with a cut-off for temocillin that was highly specific for detection of OXA-48. It is reliable and easy to apply in routine CML work flow, allowing rapid detection of CPE isolates and hence prompt implementation of infection control measures and targeted antimicrobial regimens.
产碳青霉烯酶肠杆菌科(CPE)对公共卫生构成严重威胁。临床微生物学实验室(CML)需要有效的方案来筛选和确认 CPE。
前瞻性评估一种用于检测 OXA-48 流行医院中产碳青霉烯酶肺炎克雷伯菌的筛选算法。
该算法基于使用厄他培南和替莫西林的纸片扩散试验,该试验也可作为常规自动化抗菌药物敏感性试验的纯度检查。所有最小抑菌浓度(MIC)>0.5 毫克/升或厄他培南(标准 1)抑菌圈直径<25 毫米和替莫西林(标准 2)抑菌圈直径<12 毫米的分离株均依次进行 OXA-48 侧向流动免疫层析检测和针对 VIM、KPC 和 OXA-48 的多重聚合酶链反应检测。如果两种检测均为阴性,则进行改良 Hodge 试验或 CARBA NP 试验。
在 2 年期间,根据所提出的算法评估了 2487 株肺炎克雷伯菌,有 378 株(15.20%)符合两个标准。其中,98.68%(373/378)被确认为 OXA-48 产生菌,或来源于同一患者,其耐药表型随时间保持不变。其余 3 株肺炎克雷伯菌为 VIM 产生菌。尽管符合标准 1 和标准 2,但在 378 株分离株中,只有 2 株(0.53%)未产生碳青霉烯酶。
所描述的算法将最敏感的碳青霉烯类药物用于 CPE 检测与对 OXA-48 具有高度特异性的替莫西林截止值相结合。它可靠且易于在常规 CML 工作流程中应用,能够快速检测到 CPE 分离株,从而及时实施感染控制措施和靶向抗菌方案。